Credit Suisse’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-69,717
| Closed | -$8.85M | – | 3662 |
|
2015
Q4 | $8.85M | Sell |
69,717
-110,617
| -61% | -$14M | 0.01% | 1129 |
|
2015
Q3 | $20.6M | Buy |
180,334
+28,230
| +19% | +$3.23M | 0.02% | 668 |
|
2015
Q2 | $20.5M | Sell |
152,104
-395,338
| -72% | -$53.3M | 0.02% | 755 |
|
2015
Q1 | $70.9M | Buy |
547,442
+443,593
| +427% | +$57.5M | 0.07% | 257 |
|
2014
Q4 | $12M | Sell |
103,849
-180,404
| -63% | -$20.8M | 0.01% | 1007 |
|
2014
Q3 | $30.1M | Buy |
284,253
+8,671
| +3% | +$918K | 0.02% | 642 |
|
2014
Q2 | $26.3M | Sell |
275,582
-53,329
| -16% | -$5.09M | 0.02% | 683 |
|
2014
Q1 | $29.9M | Buy |
328,911
+218,422
| +198% | +$19.9M | 0.03% | 565 |
|
2013
Q4 | $9.78M | Buy |
110,489
+10,489
| +10% | +$928K | 0.01% | 1102 |
|
2013
Q3 | $8.27M | Buy |
100,000
+4,483
| +5% | +$371K | 0.01% | 1050 |
|
2013
Q2 | $6.54M | Buy |
+95,517
| New | +$6.54M | 0.01% | 1171 |
|